RxDoctor Payments Data

Seth Bernard, DO

Family Medicine · Burton, MINPI 1720047889

Payments from drug & device makers

$760in general payments, 2019–2025

Across 28 payments — averaging $27.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$278
  • Johnson & Johnson$88
  • AbbVie$81
  • GSK$78
  • Exact Sciences$43
  • Otsuka America Pharmaceutical, Inc.$38
  • plus $154 from 9 others

What the payments were for

  • Food & beverage$74698%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$760 in reported general payments places this provider in the 65th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$12,218
Medicare patients
56
Services billed
191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide171$225,864
JardianceEmpagliflozin131$118,442
EliquisApixaban69$89,844
RybelsusSemaglutide46$61,508
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$48,707
BiktarvyBictegrav/Emtricit/Tenofov Ala12$46,819
MounjaroTirzepatide33$42,925
TrulicityDulaglutide28$42,493
Repatha SureclickEvolocumab45$35,659
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr56$32,143
FarxigaDapagliflozin Propanediol26$29,377
LinzessLinaclotide35$28,481
XareltoRivaroxaban19$26,143
Teriparatide12$24,268
MyrbetriqMirabegron21$22,992

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$78$89,699114 claims
Lilly USA, LLCMounjaro, Trulicity$13$85,41861 claims
AbbVieLinzess, Restasis$81$35,76747 claims
Johnson & JohnsonXarelto$88$26,14319 claims
Astellas Pharma US IncMyrbetriq$26$22,99221 claims
MerckJanuvia$17$12,49613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Burton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →